Shimadzu Europe
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: E-News

E-News

arrayjet

Arrayjet partners with Chemspace to amplify its small molecule microarray services

, 13 September 2023/in E-News /by panglobal

Arrayjet, a leading provider of inkjet liquid-handling solutions, has partnered with Chem-space, the largest online catalogue of small molecules and biologics, to augment and streamline the company’s small molecule microarray (SMM) service offering. Chemspace’s curated and deeply annotated compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services for assay development, contract screening and contract […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/arrayjet.jpg 896 832 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 07:57:152023-09-13 08:08:28Arrayjet partners with Chemspace to amplify its small molecule microarray services
enipcom The IGX Platform

ENPICOM secures more financing to extend data-driven antibody discovery

, 13 September 2023/in E-News /by panglobal

ENPICOM, an innovative bioinformatics software engineering company, has secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital. This underscores investor confidence in ENPICOM’s vision, unique technological capabilities, and exceptional track record in serving customers in the pharmaceutical and biotech industries.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/enipcom-The-IGX-Platform.jpg 1279 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 07:42:052023-09-13 07:42:05ENPICOM secures more financing to extend data-driven antibody discovery
Blake Simmons Transomic Technologies

ERS Genomics grants Transomic access to CRISPR/Cas9 portfolio

, 13 September 2023/in E-News /by panglobal

In a non-exclusive licensing agreement, ERS Genomics has granted Transomic Technologies access to the foundational ERS CRISPR/Cas9 patent portfolio.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Blake_Simmons_Transomic_Technologies.jpg 400 300 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 07:39:202023-09-13 07:39:20ERS Genomics grants Transomic access to CRISPR/Cas9 portfolio
Scherm­afbeelding 2023 09 13 om 09.32.48 e1694590519226

TransCure bioServices expands reach into APAC with Preclina partnership

, 13 September 2023/in E-News /by panglobal

TransCure bioServices, a humanized mouse model CRO, has partnered with Preclina, a South Korean preclinical CRO specializing in autoimmune and inflammatory diseases. The partnership significantly expands TransCure’s reach into the APAC region, while also bolstering its service offerings to further enhance the quality of its research results.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Scherm­afbeelding-2023-09-13-om-09.32.48-e1694590519226.png 182 1250 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 07:36:352023-09-13 07:36:35TransCure bioServices expands reach into APAC with Preclina partnership
Rheavita SVU

Coriolis Pharma and Rhea­Vita collab to advance drug development with novel freeze-drying technology

, 13 September 2023/in E-News /by panglobal

Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of bio-pharmaceutical drugs, will collaborate with RheaVita in an effort to pave the way for drug development of biologics using RheaVita’s novel single vial unit (SVU) technology for continuous and controlled freeze-drying technology, particularly to stabilize novel […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Rheavita_SVU.jpg 1359 1000 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-13 07:30:272023-09-13 07:30:27Coriolis Pharma and Rhea­Vita collab to advance drug development with novel freeze-drying technology
Screenshot 2023 09 04 at 16.25.32

TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration

, 5 September 2023/in E-News /by panglobal

• Novel non-viral gene delivery platform to help advance tissue repair following orthopaedic surgery • Funding from Innovate UK’s Transforming Medicines Manufacturing programme supporting innovative technologies for intracellular drug delivery

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/09/Screenshot-2023-09-04-at-16.25.32.jpg 562 988 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-09-05 07:26:312023-09-05 07:26:31TherageniX and University of Nottingham Awarded £995K Innovate UK Grant to Develop Powdered Gene Therapy for Bone Regeneration

AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

, 7 July 2023/in E-News /by panglobal

AntlerA Norrin/Wnt-agonist antibody, through a strategic partnership with EyeBio, has entered clinical trials for treatment of retinopathies.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 0 0 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-07-07 18:30:152023-07-07 18:30:15AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio
Genomic Vision 1881778573

Genomic Vision secures distribution agreement with CliniSciences

, 7 July 2023/in E-News /by panglobal

Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the characterization of DNA sequences, has secured an exclusive European distribution agreement with CliniSciences.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/07/Genomic-Vision_1881778573.jpg 1280 1920 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-07-07 18:28:142023-07-07 18:28:14Genomic Vision secures distribution agreement with CliniSciences
GBA USA

GBA Group enters US market to support growing demand from international clients

, 7 July 2023/in E-News /by panglobal

GBA Group, a leading European life science service provider, has entered the U.S. market with a site in Westborough, Massachusetts to support clinical trials. Located in the greater Boston area, a pharmaceutical and biotech hub, the laboratory and logistics site will be fully operational in October this year and will offer a broad range of […]

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/07/GBA_USA.jpg 750 1200 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-07-07 18:25:142023-07-07 18:25:14GBA Group enters US market to support growing demand from international clients
Samantha Macro

CN Bio appoints Dr Samantha Macro as CFO

, 7 July 2023/in E-News /by panglobal

Appointment part of company’s ambitious global growth strategy CN Bio, one of the world’s leading Organ-on-a-Chip companies has appointed Dr Samantha Macro as Chief Financial Officer. Dr Macro joins CEO, Dr Paul Brooks, on the executive board to guide key commercial and strategic initiatives, increase revenue and shape the company’s growth trajectory.

Read more
https://clinlabint.com/wp-content/uploads/sites/2/2023/07/Samantha-Macro.jpg 960 895 panglobal https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png panglobal2023-07-07 18:23:172024-08-21 13:47:12CN Bio appoints Dr Samantha Macro as CFO
Page 33 of 227«‹3132333435›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

November 2025

CLi Cover nov 2025
13 November 2025

New Chromsystems Product for Antiepileptic Drugs Testing

11 November 2025

Trusted analytical solutions for reliable results

10 November 2025

Chromsystems | Therapeutic Drug Monitoring by LC-MS/MS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription